Biologics Translational PKPD Modeling & DMPK Specialist

Biologics Translational PKPD Modeling & DMPK Specialist

Arbetsbeskrivning

Do you have expertise in DMPK science and PKPD modelling of antibody-based therapeutics? Would you like to apply your knowledge in a global company that follows the science and turns ideas into life-changing medicines? Then you could be the new colleague we are looking for!

Our team is growing, and we have an exciting opportunity for a passionate PKPD modelling and DMPK Scientist to join our DMPK department as a Biologics Translational PKPD Modelling & DMPK Specialist within Early Respiratory and Immunology (R&I). The R&I DMPK department provides drug metabolism and pharmacokinetic, as well as translational PKPD modeling & simulation support to our portfolio. This position is located at AstraZeneca's vibrant R&D site in Gothenburg, Sweden, one of AstraZeneca's three strategic science centres.

At AstraZeneca Early Respiratory & Immunology (R&I), we're proud to have an outstanding workplace culture that encourages innovation and teamwork. We are united by our vision to push the boundaries of DMPK science to transform ideas into medicines for R&I patients. Employees are empowered to express diverse perspectives - and are made to feel valued, energized and rewarded for their ideas and creativity.

What you'll do
As a Biologics Translational PKPD Modelling & DMPK Specialist you will have the opportunity to drive strategy and provide global leadership in PKPD science across our diverse portfolio, and act as role model, mentoring and guiding less experienced members of the team. You have in-depth knowledge of biologics drug discovery and a keen interest in understanding the translational PKPD of antibody-based therapeutics. In the role you would provide projects with specialist modelling input into exploring PK/PD/Efficacy in preclinical models and use them to guide an understanding of the dosing across different patient populations. Your level of professional experience will be relevant for your initial career level (Associate Principal Scientist or Principal Scientist).

Main Duties and Responsibilities
* Being responsible for setting and implementing the departmental biologics PKPD strategy
* Representing R&I DMPK in projects and providing overall scientific leadership for cross functional collaborations involving DMPK
* Exploring the effects on target and pathway to understand the requirements for efficacy and set a candidate drug target profile (CDTP)
* Ensuring that translational PKPD approaches are embedded at the heart of project strategy and used to support design of appropriate experiments that are aligned to the strategy underpinning human dose prediction and providing input into exposure and pharmacodynamic (PD) biomarker based decision criteria
* Leading and participating in R&I strategic scientific initiatives and continuous improvement projects by providing expert M&S knowledge.
* Having a breadth of influence and impact across AstraZeneca DMPK
* Identifying, championing and developing new ideas
* Leading scientific discipline networks and acting as a focus for debate within the AstraZeneca scientific community
* Develop excellent working relations with key stakeholders within both DMPK and in the project teams, to ensure strategic alignment, strong cross discipline collaboration and communication.
* Responsible for preparing clear presentations of DMPK contributions to internal governance interactions for the projects you support.
* Providing disciplinary scientific leadership and presenting work through publications and lectures


Essential for the role

* PhD (or equivalent industrial experience) in a relevant field e.g. pharmacokinetics, pharmacology, biopharmaceutics etc.
* 7 years of industry experience in Modeling & Simulation, ideally in preclinical/translational setting with a focus on biologics
* Comprehensive understanding of biologics drug discovery, including the PK and PKPD of antibody based therapeutics.
* Experience of DMPK project facing role in pharmaceutical R&D with a variety of therapeutic antibody formats (e.g. mAbs, Fabs, bispecifics, ADCs etc).
* Track record of supporting PK, PKPD and TKPD aspects of projects, with a delivery focus and ability to meet timelines to pre-specified quality and cost
* Excellent interpersonal skills, and ability to work in cross-functional teams as well as strong scientific leadership skills
* Hands on experience of using specialist tools such as WinNonLin/Phoenix, MATLAB, R, Berkely Madonna, SimCYP or similar


Why AstraZeneca?
At AstraZeneca we're dedicated to being a Great Place to Work. Where you are empowered to push the boundaries of science and unleash your entrepreneurial spirit. There's no better place to make a difference to medicine, patients and society. An inclusive culture that champions diversity and collaboration. Always committed to lifelong learning, growth and development.

What's next!
If you are ready to make a difference - apply today, and we'll make it happen together! We welcome your application until September 8, 2023.

Where can I find out more?
Our Gothenburg site: https://www.astrazeneca.com/our-science/gothenburg.html
Life in Gothenburg: https://www.movetogothenburg.com/
Culture and atmosphere of the Gothenburg site: https://www.linkedin.com/feed/update/urn:li:activity:6496327311678410752/
Relocate to Gothenburg: https://www.astrazeneca.se/om-oss/verksamheten-i-sverige/goteborg/relocate-to-gothenburg.html

Kontaktpersoner på detta företaget

AstraZeneca

AstraZeneca

AstraZeneca

AstraZeneca

AstraZeneca

AstraZeneca

AstraZeneca

AstraZeneca

AstraZeneca

AstraZeneca

Sammanfattning

  • Arbetsplats: AstraZeneca
  • 1 plats
  • Tills vidare
  • Heltid
  • Fast månads- vecko- eller timlön
  • Publicerat: 15 augusti 2023
  • Ansök senast: 5 september 2023

Besöksadress

Pepparedsleden 1
None

Postadress

43183
0181, 43183

Liknande jobb


Bioinformatics Research Scientist

Bioinformatics Research Scientist

19 december 2024

18 december 2024

Postdoktor inom stamcellsbaserade modeller av schizofreni

Postdoktor inom stamcellsbaserade modeller av schizofreni

16 december 2024

13 december 2024